Method of limiting the spread of norovirus within a cruise ship

Information

  • Patent Grant
  • 11998650
  • Patent Number
    11,998,650
  • Date Filed
    Tuesday, January 5, 2021
    4 years ago
  • Date Issued
    Tuesday, June 4, 2024
    11 months ago
Abstract
A method of limiting the spread of the norovirus within a cruise ship comprising: identifying a surface within a common area of a cruise ship that passengers are likely to touch; and applying a silane quaternary ammonium ion or salt thereof to the surface. The common area can be an elevator and the surface an elevator button. The common area can be a stairway and the surface a handrail. The common area can be a casino. The common area can be a dining room. The common area can be a walkway and the surface a handrail. The silane quaternary ammonium ion or salt thereof can be 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium ion, 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride, 3-(trihydroxysilyl)propyldimethyloctadecyl ammonium ion, or 3-(trihydroxysilyl)propyldimethyloctadecyl ammonium chloride. Applying the silane quaternary ammonium ion or salt thereof to the surface comprises applying a solution including the silane quaternary ammonium ion or salt thereof and a solvent.
Description
BACKGROUND OF THE INVENTION

The norovirus is a virus that causes gastroenteritis. Gastroenteritis is the inflammation of the gastrointestinal tract, which includes the stomach and the small intestine. Symptoms of gastroenteritis include stomach pain, diarrhea, and vomiting. Norovirus spreads very quickly and easily, including by touching objects that have the norovirus present.


According to the United States Centers for Disease Control and Prevention (CDC), the number of outbreaks of gastroenteritis on cruise ships has increased since 2001, because of increased presence of the norovirus. The CDC even has implemented a Vessel Sanitation Program (VSP) to help cruise ships curtail outbreaks of gastroenteritis. Despite this effort, twelve cruise ships reported an outbreak of gastroenteritis caused by the norovirus in 2015. Eleven cruise ships similarly reported in 2016.


After some outbreaks, the cruise ship may undertake extensive cleaning and disinfecting. The cruise ship owners bear the cost of the cleaning and disinfecting as well as the down time.


SUMMARY OF THE INVENTION

According to an aspect of the present invention, a method of limiting the spread of norovirus within a cruise ship comprises: identifying a surface within a common area of a cruise ship that passengers are likely to touch; and applying a silane quaternary ammonium ion or salt thereof to the surface.


Embodiments of the first aspect of the invention can include any one or a combination of the following features:

    • the method further comprises identifying the presence of the norovirus within the cruise ship;
    • the method further comprises wiping the surface with a microfiber cloth;
    • the method further comprises testing the surface for the presence of the norovirus;
    • the common area is an elevator and the surface is an elevator button;
    • the common area is a stairway and the surface is a handrail;
    • the common area is a casino;
    • the common area is a dining room;
    • the common area is a walkway and the surface is a handrail;
    • the silane quaternary ammonium ion or salt is 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium ion, 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride, 3-(trihydroxysilyl)propyldimethyloctadecyl ammonium ion, or 3-(trihydroxysilyl)propyldimethyloctadecyl ammonium chloride;
    • applying a silane quaternary ammonium ion or salt thereof to the surface comprises applying, to the surface, a solution including the silane quaternary ammonium ion or salt thereof and a solvent;
    • the solvent is isopropyl alcohol;
    • the solution is applied via spraying the solution onto the surface with an electrostatic sprayer;
    • the silane quaternary ammonium ion or salt thereof is between 0.1 percent and 10 percent by weight of the solution;
    • the silane quaternary ammonium ion or salt thereof is between 0.75 percent and 5 percent by weight of the solution;
    • the silane quaternary ammonium ion or salt thereof is between 1.9 percent and 2.1 percent by weight of the solution;
    • the solvent is isopropyl alcohol and the isopropyl alcohol is between 30 percent to 90 percent by weight of the solution;
    • the isopropyl alcohol is between 55 percent and 65 percent by weight of the solution;
    • the method further comprises initially identifying the presence of the norovirus within the cruise ship, after spraying the solution onto the surface, wiping the surface with a microfiber cloth, and after wiping the surface with a microfiber cloth, waiting a preset period of time, and testing the surface for the presence of the norovirus.


These and other features, advantages, and objects of the present invention will be further understood and appreciated by those skilled in the art by reference to the following specification, claims, and appended drawings.





BRIEF DESCRIPTION OF THE DRAWINGS

In the drawings:



FIG. 1 is a perspective view of a cruise ship, illustrating numerous decks above a hull and passengers being transported over a body of water;



FIG. 2 is a perspective view of an elevator lobby common area and elevator buttons acting as surfaces which passengers are likely to touch;



FIG. 3 is a perspective view of several stairways acting as common areas and handrails acting as surfaces which passengers are likely to touch;



FIG. 4 is a perspective view of a casino acting as a common area for passengers and slot machine buttons acting as surfaces which passengers are likely to touch;



FIG. 5 is a perspective view of a dining room acting as a common area for passengers and dining table tops acting as surfaces which passengers are likely to touch;



FIG. 6 is a perspective view of a walkway common area and handrails acting as surfaces which passengers are likely to touch;



FIG. 7 is a perspective view of elevator buttons within an elevator accessible from the elevator lobby acting as surfaces which passengers are likely to touch; and



FIG. 8 is a flow chart illustrating a method of limiting the spread of norovirus within a cruise ship, including applying a quaternary ammonium ion or salt thereof to the surface of the common areas which passengers are likely to touch.





DETAILED DESCRIPTION

Referring now to FIGS. 1-7, a cruise ship 10 includes a hull 12 configured to float on, and transport passengers 14 over, a body of water 16. The cruise ship 10 further includes one or more decks 18 within and/or above the hull 12.


The cruise ship 10 further includes one or more common areas 20, which are areas that the passengers 14 are allowed to access, on the one or more decks 18. The common areas 20 include, without limitation, an elevator lobby 20a (see FIG. 2) with elevators 22 transporting passengers 14 between the one or more decks 18, stairways 20b (see FIG. 3) on which passengers 14 can move between the one or more decks 18, a casino 20c (see FIG. 4), a dining room 20d (see FIG. 5), and a walkway 20e upon which passengers 14 walk (see FIG. 6), among other areas. The common areas 20 include surfaces 24 that the passengers 14 are likely to touch with their hands and thus constitute surfaces 24 where the norovirus can transfer from passenger 14 to passenger 14. Examples of such surfaces 24 in the common areas 20 that passengers 14 are likely to touch, include, without limitation: elevator buttons 24a in the elevator lobby 20a (see FIG. 2) and in the elevators 22 (see FIG. 7); handrails 24b for the stairways 20b (see FIG. 3); slot machine screens 24c, buttons 24d, and levers 24e, gaming table tops 24f, and seatbacks 24g in the casino 20c (see FIG. 4); railings 24h, seatbacks 24g, dining table tops 24i, and place settings 24j in the dining room 20d (see FIG. 5); and handrails 24b in the walkway 20e (see FIG. 6).


Referring now to FIG. 8, at step 26, a method of limiting the spread of norovirus within the cruise ship 10 comprises identifying a surface 24 within a common area 20 of a cruise ship 10 that passengers 14 are likely to touch. Examples of such surfaces 24 in such common areas 20 are provided above. A common area 20 could include any area to which many or all of the passengers 14 have access.


The method further includes, at step 28, applying a silane quaternary ammonium ion or salt thereof to the surfaces 24. Preferred silane quaternary ammonium ions or salts thereof include 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium ion, 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride, 3-(trihydroxysilyl)propyldimethyloctadecyl ammonium ion, or 3-(trihydroxysilyl)propyldimethyloctadecyl ammonium chloride.


Applying the silane quaternary ammonium ion or salt thereof to the surface can be made by applying, to the surface 24, a solution including the silane quaternary ammonium ion or salt thereof and a solvent. The solvent can be isopropyl alcohol, among others. The silane quaternary ammonium ion or salt thereof can comprise between 0.1 percent and 10 percent by weight of the solution. More preferably, the silane quaternary ammonium ion or salt thereof can comprise between 0.75 percent and 5 percent by weight of the solution. Even more preferably, the silane quaternary ammonium ion or salt thereof can comprise between 1.9 percent and 2.1 percent by weight of the solution. As for the isopropyl alcohol, the isopropyl alcohol can comprise between 30 percent to 90 percent by weight of the solution. More preferably, the isopropyl alcohol can comprise between 55 percent and 65 percent by weight of the solution. An example preferable solution comprises (by weight) 60.0 percent isopropyl alcohol, 2.02 percent 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride, and 34.19 percent deionized water.


The solution can be applied via spraying the solution containing the silane quaternary ammonium ion or salt thereof and the solvent with an electrostatic sprayer. Alternatively, the solution can be applied with a wipe soaked with the solvent, a spray bottle containing the solvent, and other means.


Quaternary ammonium compounds are generally thought to be ineffective in destroying non-enveloped viruses. The norovirus is a non-enveloped virus. Surprisingly, testing performed pursuant to ASTM E1053 has shown that a solution including 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride as the active ingredient was an effective virucidal solution against a norovirus-like virus. Because of difficulties in propagating norovirus, surrogate viruses which are able to be propagated in cell cultures have been discovered and used for testing purposes. The virus selected for the test was Bacteriophage MS2, which is a virus that infects Escherichia coli, and is an accepted surrogate virus for norovirus. Like norovirus, Bacteriophage MS2 is a non-enveloped virus.


For the testing, Petri dish carriers (a sufficient number for both test and control) were presented. The test Petri dish carriers were then sprayed five times with the solution including 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride as the active ingredient. The test Petri dish carriers were sprayed at a distance of between eight and ten inches and at an angle of 45 degrees. The solution was shaken before being sprayed. The test Petri dish carriers with the solution applied thereon were then allowed to dry for fifty-eight minutes. The control Petri dish carriers were not sprayed with the solution including 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride as the active ingredient.


Both the test and control Petri dish carriers were then inoculated with the Bacteriophage MS2 virus. Specifically, the carriers were inoculated with 0.2 ml of the virus, which was spread on the entire surface area on the carrier (10-in2). At time zero, the PFU/Carrier for the control carrier was measured at 9.25E+06. The carriers were then held for twenty-four hours.


Both the test and control carriers were neutralized and the level of the Bacteriophage MS2 virus remaining in each was determined. After the 24 hours holding time, the PFU/Carrier for the control carrier was 1.43E+06, and the PFU/Carrier for the test carrier was 2.95E+04. Thus, the log10 reduction compared to time zero was 0.81 for the control and 2.50 for the test (the carrier sprayed with the solution containing 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride as the active ingredient). The percent reduction compared to time zero was 84.6 percent for the control and 99.7 percent for the test. The log10 reduction for the test compared to the control was 1.68. The percent reduction for the test compared to the control was 97.9 percent. This testing surprisingly demonstrated that the solution containing 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride as the active ingredient satisfied the criteria for passing ASTM E1053, because a greater than 3-log10 reduction was observed in the test carrier compared to the control carrier.


The method can optionally further include, at step 30, identifying the presence of the norovirus within the cruise ship 10. Applying a silane quaternary ammonium ion or salt thereof to the surface 24 set forth above, to limit the spread of the norovirus within a cruise ship 10, can be performed either before the presence of the norovirus has been identified (as a preventative measure) or after the presence of norovirus has been identified (as a consequential measure to limit the spread of the norovirus and to reduce the amount of norovirus within the cruise ship to acceptable levels). The presence of the norovirus can be identified, for example, after an outbreak of sickness on the cruise ship 10. Documenting the existence of gastroenteritis among numerous passengers 14 of the cruise ship 10 can give rise to the assumed identification of the norovirus within the cruise ship 10.


The method can optionally further include, at step 32, wiping the surface 24 with a microfiber cloth. If the solution including the silane quaternary ammonium ion or salt thereof has been applied to the surface 24 via spraying, then beads of the solution may develop on the surface 24. Wiping the surface 24 with a microfiber cloth spreads the solution and therefore the silane quaternary ammonium ion or salt thereof over the surface 24 more uniformly.


The method can optionally further include, at step 34, testing the surface 24 for the presence of the norovirus. After the solution including the silane quaternary ammonium ion or salt thereof has been applied to the surface 24, and after waiting a preset time (such as 24 hours), the surface 24 can be tested for the presence of the norovirus. Such testing can confirm that the silane quaternary ammonium ion or salt thereof applied to the surface 24 has effectively eliminated the norovirus from the surface 24. Alternatively, such testing can confirm whether another application of the silane quaternary ammonium ion or salt thereof to the surface 24 may be required to effectively eliminate the norovirus from the surface 24.

Claims
  • 1. A method of limiting spread of a virus within a cruise ship comprising: applying, to a surface of a common area of a cruise ship, a solution comprising a silane quaternary ammonium ion or salt thereof and 55 percent and 65 percent by weight isopropyl alcohol;wherein, the silane quaternary ammonium ion or salt comprises one or more of: 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium ion, 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride, 3-(trihydroxysilyl)propyldimethyloctadecyl ammonium ion, and 3-(trihydroxysilyl)propyldimethyloctadecyl ammonium chloride.
  • 2. The method of claim 1 further comprising: wiping the surface with a microfiber cloth.
  • 3. The method of claim 1 further comprising: testing the surface for presence of a virus, after applying the solution, to confirm that the solution has effectively eliminated the virus from the surface.
  • 4. The method of claim 1, wherein the common area is an elevator and the surface is an elevator button.
  • 5. The method of claim 1, wherein the common area is a stairway and the surface is a handrail.
  • 6. The method of claim 1, wherein the common area is a casino.
  • 7. The method of claim 1, wherein the common area is a dining room.
  • 8. The method of claim 1, wherein the common area is a walkway and the surface is a handrail.
  • 9. The method of claim 1, wherein the solution is applied by spraying the solution onto the surface with an electrostatic sprayer.
  • 10. The method of claim 1, wherein the silane quaternary ammonium ion or salt thereof is between 0.1 percent and 10 percent by weight of the solution.
  • 11. The method of claim 1, wherein the silane quaternary ammonium ion or salt thereof is between 0.75 percent and 5 percent by weight of the solution.
  • 12. The method of claim 1, wherein the silane quaternary ammonium ion or salt thereof is between 1.9 percent and 2.1 percent by weight of the solution.
  • 13. The method of claim 1, wherein applying the solution comprises: applying, via spraying onto the surface with an electrostatic sprayer, the solution, wherein the solution comprises 0.1 percent to 10 percent by weight 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium ion or 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride.
  • 14. The method of claim 13 further comprising: before applying the solution, identifying presence of a virus within the cruise ship;after spraying the solution onto the surface, wiping the surface with a microfiber cloth; andafter wiping the surface with the microfiber cloth, waiting a preset period of time, and testing the surface for the presence of the virus;wherein, the common area is one of an elevator, a stairway, a casino, a dining room, or a walkway.
  • 15. The method of claim 1, wherein the virus is a norovirus.
  • 16. The method of claim 1 further comprising: before applying the solution to the surface, documenting an existence of gastroenteritis among passengers of the cruise ship.
  • 17. The method of claim 16 further comprising: identifying the surface as one that passengers are likely to touch and spread a virus.
  • 18. A method of limiting spread of a norovirus within a cruise ship comprising: applying, to a surface of a common area of a cruise ship, a solution comprising a silane quaternary ammonium ion or salt thereof and 55 percent and 65 percent by weight isopropyl alcohol;wherein, the silane quaternary ammonium ion or salt comprises one or more of: 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium ion, 3-(trimethoxysilyl)propyldimethyloctadecyl ammonium chloride, 3-(trihydroxysilyl)propyldimethyloctadecyl ammonium ion, and 3-(trihydroxysilyl)propyldimethyloctadecyl ammonium chloride.
CROSS-REFERENCE TO RELATED APPLICATION

This application is a continuation of and claims priority to U.S. patent application Ser. No. 15/807,157, filed on Nov. 8, 2017, entitled “METHOD OF LIMITING THE SPREAD OF NOROVIRUS WITHIN A CRUISE SHIP,” now U.S. Pat. No. 10,967,082, the entire disclosure of which is incorporated herein by reference.

US Referenced Citations (287)
Number Name Date Kind
3241152 Hay Mar 1966 A
3515131 Stevens Jun 1970 A
3654165 Bryant et al. Apr 1972 A
4017662 Gehman et al. Apr 1977 A
4266669 Watson May 1981 A
4282366 Eudy Aug 1981 A
4372303 Grossmann et al. Feb 1983 A
4394378 Klein Jul 1983 A
4414268 Baldwin Nov 1983 A
4504541 Yasuda et al. Mar 1985 A
4603152 Laurin et al. Jul 1986 A
4735198 Sawa Apr 1988 A
4797420 Bryant Jan 1989 A
4865844 Blank et al. Sep 1989 A
4891846 Sager et al. Jan 1990 A
4921691 Stockel May 1990 A
5003970 Parker et al. Apr 1991 A
5079004 Blank et al. Jan 1992 A
5183664 Ansell Feb 1993 A
5193549 Bellin et al. Mar 1993 A
5270358 Asmus Dec 1993 A
5277698 Taylor Jan 1994 A
5411585 Avery et al. May 1995 A
5428078 Cohen et al. Jun 1995 A
5466898 Gilbert et al. Nov 1995 A
5520664 Bricault, Jr. et al. May 1996 A
5592946 Eddy Jan 1997 A
5620001 Byrd et al. Apr 1997 A
5660182 Kuroshaki et al. Aug 1997 A
5685866 Lopez Nov 1997 A
5762623 Murphy et al. Jun 1998 A
5954869 Elfersy et al. Sep 1999 A
5959014 Liebeskind et al. Sep 1999 A
6186957 Milam Feb 2001 B1
6221944 Liebeskind et al. Apr 2001 B1
6224579 Modak et al. May 2001 B1
6344025 Inagaki et al. Feb 2002 B1
6420455 Landgrebe et al. Jul 2002 B1
6492012 Shah Dec 2002 B1
6495229 Carte et al. Dec 2002 B1
6520281 Deslauriers et al. Feb 2003 B1
6575917 Giroux et al. Jun 2003 B2
6738986 Martin May 2004 B1
6803034 DuVal et al. Oct 2004 B2
6821936 Green et al. Nov 2004 B2
6821943 Avery et al. Nov 2004 B2
6822030 Olson et al. Nov 2004 B2
6994890 Ohlhausen et al. Feb 2006 B2
7045673 Batich et al. May 2006 B1
7081101 Sawa Jul 2006 B1
7201914 Dees Apr 2007 B2
7645824 Hendriks et al. Jan 2010 B2
7674473 Falder et al. Mar 2010 B2
7704313 Ohlhausen et al. Apr 2010 B2
7709694 Batich et al. May 2010 B2
7731564 Sanders Jun 2010 B2
7754004 Ohlhausen et al. Jul 2010 B2
7754625 Hendriks et al. Jul 2010 B2
7790217 Toreki et al. Sep 2010 B2
8025120 Eddy Sep 2011 B2
8178484 Schwarz et al. May 2012 B2
8257780 Ohlhausen et al. Sep 2012 B2
8440217 El-Naggar et al. May 2013 B1
8449483 Eddy May 2013 B2
8491922 Eddy Jul 2013 B2
8574844 Burkhardt, III et al. Nov 2013 B2
8639527 Rensvold et al. Jan 2014 B2
8679526 Van Den Plas et al. Mar 2014 B2
8916742 Smith Dec 2014 B2
8956665 Bolkan et al. Feb 2015 B2
8999363 Elfersy Apr 2015 B2
9028846 Eddy May 2015 B2
9089138 Higgins et al. Jul 2015 B2
9095731 Gentle et al. Aug 2015 B2
9149393 Cumming et al. Oct 2015 B2
9204677 Abbey et al. Dec 2015 B2
9215903 Abbey et al. Dec 2015 B2
9254591 Fox et al. Feb 2016 B2
9375346 Sundheimer et al. Jun 2016 B1
9433708 Eddy Sep 2016 B2
9675735 Eddy Jun 2017 B2
9717249 Eddy Aug 2017 B2
9757769 Grossman et al. Sep 2017 B2
9795141 Chason et al. Oct 2017 B2
9795177 Weaver Oct 2017 B1
9834874 Stein Dec 2017 B2
9840626 Farrugia et al. Dec 2017 B2
9845569 Dunn et al. Dec 2017 B2
9855584 Grossman et al. Jan 2018 B2
9877875 Eddy Jan 2018 B2
9877879 Beck Jan 2018 B2
9943135 Baychar Apr 2018 B2
10039683 Jung et al. Aug 2018 B2
10045536 Chason et al. Aug 2018 B2
10212932 Chiattello et al. Feb 2019 B2
10258046 Grossman et al. Apr 2019 B2
10258411 Ferguson Apr 2019 B1
10306884 Howard, Jr. Jun 2019 B1
10388143 Eddy et al. Aug 2019 B2
10470689 Kilcran et al. Nov 2019 B2
10472157 Dudding et al. Nov 2019 B1
10758426 Eddy Sep 2020 B2
10822502 Eddy Nov 2020 B2
10864058 Eddy Dec 2020 B2
10967082 Eddy Apr 2021 B2
20020111282 Charaf et al. Aug 2002 A1
20020170771 Milam et al. Nov 2002 A1
20030073600 Avery et al. Apr 2003 A1
20040019286 Lia et al. Jan 2004 A1
20040151919 Bagwell et al. Aug 2004 A1
20040166173 Albach Aug 2004 A1
20050008763 Schachter Jan 2005 A1
20050035164 Badillo Feb 2005 A1
20050187580 Skiba Aug 2005 A1
20050227895 Ghosh et al. Oct 2005 A1
20060127498 Sugiura Jun 2006 A1
20060223962 Getman et al. Oct 2006 A1
20060293623 Carroll Dec 2006 A1
20070021383 Loder Jan 2007 A1
20070038132 Kishimoto et al. Feb 2007 A1
20070038243 Rutherford Feb 2007 A1
20070042198 Schonemyr et al. Feb 2007 A1
20070065475 Elfersy Mar 2007 A1
20070088224 Friedman et al. Apr 2007 A1
20070129636 Friedman et al. Jun 2007 A1
20070166344 Qu et al. Jul 2007 A1
20070193822 Statner et al. Aug 2007 A1
20070218096 Wooley Sep 2007 A1
20070227930 Bromberg et al. Oct 2007 A1
20070275929 Fuls et al. Nov 2007 A1
20080033329 Downs et al. Feb 2008 A1
20080166384 Jones Jul 2008 A1
20080171068 Wyner et al. Jul 2008 A1
20080193497 Samuelsen et al. Aug 2008 A1
20080236596 Pierskalla et al. Oct 2008 A1
20080242794 Sandford et al. Oct 2008 A1
20080260804 Morris et al. Oct 2008 A1
20080264445 Levitt et al. Oct 2008 A1
20090074881 Kielbania, Jr. Mar 2009 A1
20090196896 Patton et al. Aug 2009 A1
20090215917 Trotter et al. Aug 2009 A1
20090223411 Higgins et al. Sep 2009 A1
20090227454 Jaiswal Sep 2009 A1
20090252647 Orofino Oct 2009 A1
20090259157 Thomas Oct 2009 A1
20090281368 Krubsack et al. Nov 2009 A1
20090285890 Van Den Plas et al. Nov 2009 A1
20090288908 Giroux et al. Nov 2009 A1
20090291147 Sandford et al. Nov 2009 A1
20090307843 Hookway et al. Dec 2009 A1
20090312684 Leonard et al. Dec 2009 A1
20100028462 Bolkan et al. Feb 2010 A1
20100032231 Statner et al. Feb 2010 A1
20100056485 Park Mar 2010 A1
20100063431 Bae Mar 2010 A1
20100086580 Nyman et al. Apr 2010 A1
20100089408 McCaughey et al. Apr 2010 A1
20100113871 Dias et al. May 2010 A1
20100137764 Eddy Jun 2010 A1
20100159256 Yamasaki et al. Jun 2010 A1
20100167978 Iyer et al. Jul 2010 A1
20100197748 Schwarz et al. Aug 2010 A1
20100255178 Leander et al. Oct 2010 A1
20100331710 Eddy Dec 2010 A1
20110084578 Newkirk et al. Apr 2011 A1
20110124772 Wang et al. May 2011 A1
20110186462 Storey et al. Aug 2011 A1
20110200655 Black et al. Aug 2011 A1
20110209835 Balbona et al. Sep 2011 A1
20110233810 Neigel et al. Sep 2011 A1
20110236504 Hata et al. Sep 2011 A1
20110245743 Eddy Oct 2011 A1
20110250626 Williams et al. Oct 2011 A1
20110271873 Ohlhausen et al. Nov 2011 A1
20110282302 Lopez et al. Nov 2011 A1
20120015200 Ali et al. Jan 2012 A1
20120021405 Palzkill et al. Jan 2012 A1
20120052106 Eddy Mar 2012 A1
20120052289 Jing et al. Mar 2012 A1
20120070481 Bolkan et al. Mar 2012 A1
20120070509 Sugiura Mar 2012 A1
20120134953 Gentle et al. May 2012 A1
20120135188 Proton May 2012 A1
20120136313 Smith May 2012 A1
20120157567 Ou et al. Jun 2012 A1
20120157904 Stein Jun 2012 A1
20120173274 Rensvold et al. Jul 2012 A1
20120246788 Harrell et al. Oct 2012 A1
20120263910 Baychar Oct 2012 A1
20120296252 Cumming et al. Nov 2012 A1
20130017242 Richardson et al. Jan 2013 A1
20130045265 Chapman Feb 2013 A1
20130101674 Toft Apr 2013 A1
20130101677 Callahan et al. Apr 2013 A1
20130231599 Eddy Sep 2013 A1
20130273132 Eddy Oct 2013 A1
20130273133 Eddy Oct 2013 A1
20130338553 Eddy Dec 2013 A1
20130345170 Eddy Dec 2013 A1
20140011766 Krafft Jan 2014 A1
20140051732 Ghannoum et al. Feb 2014 A1
20140066869 Toft Mar 2014 A1
20140100504 Eddy Apr 2014 A1
20140199356 Chason et al. Jul 2014 A1
20140199358 Chason et al. Jul 2014 A1
20140199359 Chason et al. Jul 2014 A1
20140221876 Eddy Aug 2014 A1
20140256382 Eddy Sep 2014 A1
20140271794 Eddy Sep 2014 A1
20140276456 Eddy Sep 2014 A1
20140302168 Perry Oct 2014 A1
20140326192 Coupe et al. Nov 2014 A1
20140352039 Abbey et al. Dec 2014 A1
20150004361 Culpepper Jan 2015 A1
20150005684 Evans Jan 2015 A1
20150011716 Lombardi Jan 2015 A1
20150024019 Ali et al. Jan 2015 A1
20150031729 Ghannoum et al. Jan 2015 A1
20150080827 Fogg Mar 2015 A1
20150086597 Mallak et al. Mar 2015 A1
20150089720 Abbey et al. Apr 2015 A1
20150143615 LePage May 2015 A1
20150158608 Talarico Jun 2015 A1
20150305343 Burke et al. Oct 2015 A1
20150328240 Hilliard et al. Nov 2015 A1
20150352320 Eddy Dec 2015 A1
20160051389 Seligman Feb 2016 A1
20160107411 Fox et al. Apr 2016 A1
20160143275 Lan et al. May 2016 A1
20160143276 Lan et al. May 2016 A1
20160151189 Romo et al. Jun 2016 A1
20160171179 Donofrio et al. Jun 2016 A1
20160262382 Lan et al. Sep 2016 A1
20160262383 Lan et al. Sep 2016 A1
20160295858 Mason et al. Oct 2016 A1
20160354005 Oakley et al. Dec 2016 A1
20160361478 Eddy Dec 2016 A1
20170000115 Nassar et al. Jan 2017 A1
20170000651 Cumming et al. Jan 2017 A1
20170027269 Wilson et al. Feb 2017 A1
20170081707 Dillon et al. Mar 2017 A1
20170106622 Bonin Apr 2017 A1
20170176146 Böhringer et al. Jun 2017 A1
20170224043 Bouchard-Fortin et al. Aug 2017 A1
20170236398 Eddy et al. Aug 2017 A1
20170246041 Cumming et al. Aug 2017 A1
20170265475 Chason et al. Sep 2017 A1
20170274114 Song et al. Sep 2017 A1
20170280716 Lan et al. Oct 2017 A1
20170319758 Eddy et al. Nov 2017 A1
20170367899 Lundh et al. Dec 2017 A1
20180028431 Chiattello et al. Feb 2018 A1
20180055695 Park Mar 2018 A1
20180080605 Janway et al. Mar 2018 A1
20180139959 Nassar et al. May 2018 A1
20180224674 Carabin Aug 2018 A1
20180243790 Grossman et al. Aug 2018 A1
20190046081 Kilcran et al. Feb 2019 A1
20190046082 Kilcran et al. Feb 2019 A1
20190046083 Kilcran et al. Feb 2019 A1
20190046084 Kilcran et al. Feb 2019 A1
20190046364 Kilcran et al. Feb 2019 A1
20190051137 Kilcran et al. Feb 2019 A1
20190125774 Eddy May 2019 A1
20190134244 Eddy May 2019 A1
20190166828 Storey et al. Jun 2019 A1
20190209381 Cumming et al. Jul 2019 A9
20190216090 Alimi et al. Jul 2019 A1
20190223445 Seo et al. Jul 2019 A1
20190254865 Eddy Aug 2019 A1
20190255210 Eddy Aug 2019 A1
20190276681 Eddy Sep 2019 A1
20190289954 Baychar Sep 2019 A1
20190298479 Eddy Oct 2019 A1
20190360781 Böhringer et al. Nov 2019 A1
20200022421 Kilbey Jan 2020 A1
20200068896 Eddy Mar 2020 A1
20200071540 Eddy Mar 2020 A1
20200095775 Eddy Mar 2020 A1
20200097936 Eddy Mar 2020 A1
20200281288 Eddy Sep 2020 A1
20200281774 Eddy Sep 2020 A1
20200282099 Eddy Sep 2020 A1
20210052345 Eddy Feb 2021 A1
20210137120 Eddy et al. May 2021 A1
20210299307 Eddy Sep 2021 A1
20210299309 Eddy Sep 2021 A1
Foreign Referenced Citations (19)
Number Date Country
0108853 May 1984 EP
0129980 Jan 1985 EP
1600105 Nov 2005 EP
2377400 Oct 2011 EP
2200594 Aug 1988 GB
1020060055894 May 2006 KR
2540478 Feb 2015 RU
2599004 Oct 2016 RU
0054587 Sep 2000 WO
0072850 Dec 2000 WO
2004087226 Oct 2004 WO
2005042657 May 2005 WO
2007061625 May 2007 WO
2007076413 Jul 2007 WO
2008076839 Jun 2008 WO
2008097599 Aug 2008 WO
2012037615 Mar 2012 WO
2013102021 Jul 2013 WO
2016130837 Aug 2016 WO
Non-Patent Literature Citations (30)
Entry
Murray et al., “Microbial Inhibition on Hospital Garments Treated with Dow Corning 5700 Antimicrobial Agent,” Journal of Clinical Microbiology, vol. 26, No. 9, Sep. 1988, pp. 1884-1886.
Rutala et al., “Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008,” Centers for Disease Control (CDC), Department of Health & Human Services, Feb. 15, 2017 (161 pages).
U.S. Food & Drug Administration (FDA), “Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling Guidance for Industry and Food and Drug Administration Staff,” Mar. 17, 2015 (44 pages).
European Commission, “Aerosol Dispensers Directive Evaluation—Background document”, Sep. 23, 2016, Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, Belgium (1 page).
Monticello, Robert A., “The Use of Reactive Silane Chemistries to Provide Durable, Non-Leaching Antimicrobial Surfaces”, AEGIS Environments, Midland, Michigan USA, Jan. 1, 2010 (77 pages).
AEGIS Environments, Material Safety Data Sheet Aegis Microbe Shield(TM) Program—AEGIS(TM) Antimicrobial (Typical Application Strength), Midland, Michigan USA, May 12, 2004 (5 pages).
Federal Institute of Industrial Property, “The International Search Report and the Written Opinion of the International Searching Authority,” dated Jan. 24, 2019 (9 pages).
World Health Organization, “Guide to marine sanitation,” Third Edition, 2013, pp. 90 and 147-149.
Jimenez et al: “Virucidal activity of a quaternary ammonium compound disinfectant against feline calicivirus: A surrogate for norovirus”, AJIC: American Journal of Infection Control, vol. 34, No. 5, Jun. 1, 2006 (Jun. 1, 2006), pp. 269-273, Elsevier, Amsterdam, NL.
Anonymous: “Guidance for the Management of Norovirus Infection in Cruise Ships”, ⋅ Jul. 1, 2007 (Jul. 1, 2007), pp. 1-76, Retrieved from the Internet: URL:https://virox.com/files docs/content/pdf/msds/1206520183347.pd, [retrieved on Jan. 28, 2021].
Anonymous.: “Guide to ship sanitation (third edition)”, Guide to Ship Sanitation (Third Edition), World Health Organization, CH, pp. 1-171, Nov. 30, 2012 (Nov. 30, 2012), Retrieved from the Internet: URL: https://www.who.int/water sanitation health/publications/2011/ship-sanitation-guide/en/, pp. 133-135.
Extended European Search Report, European Application No. 18875379.2, dated Feb. 11, 2021 (6 pages).
Anonymous. 2009. SiSiB PC9911 Antimicrobial. Power Chemical Corp. [online]; downloaded from URL<http://www.powerchemcorp.com/library/public/SiSiB_PC9911.pdf> on Oct. 8, 2013; 2 pages.
http://www.ncbi.nlm.nih.gov/pubmed/7753434, 1995 [retrieved on Dec. 4, 2012].
“Graft Polymerization onto Wool Pretreated with a Mercaptosilane”, Textile Research Journal, Aug. 1996, vol. 66, No. 8, 529-532.
Sickbert-Bennett et al., “Comparative Efficacy of Hand Hygiene Agents in the Reductions of Bacteria and Viruses”, 2005, pp. 67-77, vol. 33, No. 2, Association for Professionals in Infection Control and Epidemiology, Inc.
http://www.bovie.com/germgate-factsheet1.html [retrieved on Jun. 10, 2010].
http://www.andonline.com/and_med.nsf/html/UA-851THW [retrieved on Jun. 10, 2010].
http://www.zorotools.com/g/Respirator%20Antimicrobial%20Wipes/00118290 [retrieved on Dec. 4, 2012].
ICU Medical, Inc., “MicroClave Neutral Displacement Connector”, 2012, M1-1113 Rev. 10, 4 pages.
ICU Medical, Inc., “Antimicrobial MicroClave Neutral Displacement Connector”, 2012, M1-1248 Rev. 04, 2 pages.
Anonymous: “Guide to ship sanitation (third edition)”, 2011, pp. iii-155 (total pages 171), World Health Organization, Switzerland.
Proguard Quaternary Disinfectant (http://www.kellysolutions.com/wa/showA 1.asp?Basic_EPA_ID=6836%2D78&EPA_ID=6836%2D78%2D1677&Product_Name=Quaternary+Disinfectant+Cleaner+ProGuard (downloaded on Jun. 26, 2013)).
Sarah Coleman, To Bandage or Not To Bandage: Decoding Thoroughbred Leg Wrappings, Dec. 22, 2015, pp. 1-4 https://www.paulickreport.com/horse-care-category/the-great-bandage-debate-decoding-thoroughbred-leg-wrappings/ (Year: 2015).
A-Tape Cohesive Crepe Bandage Red (Pack 2) Elastic Self Adhesive (10 cm x 4.5 mtr) hhttps://www.amazon.in/Bandages-Assorted-Colors-Waterproof-Adherent/dp/B01I62O0CM (Year: 2016).
Measurement Canada document (https://www.ic.gc.ca/eic/site/mc-mc.nsf/vwapj/VCF-FCV_CAS-67-63-0.pdf/$file/NCF-FCV_CAS-67-63-0.pdf, accessed Apr. 15, 2016, pp. 1-2).
Mahltig B., Grethe T., Haase H. (Jun. 1, 2018) Antimicrobial Coatings Obtained by Sol-Gel Method. In: Klein L., Aparicio M., Jitianu A. (eds) Handbook of Sol-Gel Science and Technology. Springer, Cham. (“Antimicrobial”).
https://www.fullerindustriesllc.com/franklin-cleaning-technology/quasar/, [retrieved on Nov. 16, 2021].
European Patent Office, “Extended European Search Report”, European Application No. 19194187.1, dated Nov. 18, 2019 (12 pages).
http://www.igenericdrugs.com/?s= Life%20Brand%20Disinfectant%20Wipes [retrieved on Dec. 4, 2012].
Related Publications (1)
Number Date Country
20210121591 A1 Apr 2021 US
Continuations (1)
Number Date Country
Parent 15807157 Nov 2017 US
Child 17141756 US